In tumor tissue (TT), their numbers are typically reduced, and their functions are inhibited by tumor cytokines, such as interleukin-10 (IL-10), resulting in the emergence of immune tolerance and the proliferation of regulatory T cells (Tregs). This evidence concerns the gene IL10 and neoplasm.